Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study

Published:2014 Issue:8 Volume:19 Page:755-764
ISSN:1359-6535
Container-title:Antiviral Therapy
language:
Short-container-title:Antivir Ther

Author:

Tseng Kuo-Chih,Chen Chi-Yi,Tsai Hung-Wen,Chang Ting-Tsung,Chuang Wan-Long,Hsu Ping-I,Liu Wen-Chun,Cheng Pin-Nan

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte-Infiltrated Periportal Region Detection With Structurally-Refined Deep Portal Segmentation and Heterogeneous Infiltration Features;IEEE Open Journal of Engineering in Medicine and Biology;2024

2. Entecavir for children and adults with chronic hepatitis B;Cochrane Database of Systematic Reviews;2023-02-27

3. Virological Changes of Chronic Hepatitis B Patients with Minimally Elevated Levels of Alanine Aminotransferase: A Meta-Analysis and Systematic Review;Canadian Journal of Gastroenterology and Hepatology;2022-11-16

4. HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?;Journal of Clinical and Translational Hepatology;2022-03-17

5. Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial;The Lancet Infectious Diseases;2021-06